Recent News

CryoPen, Inc. Participates in Marketplace at the U.S. - Africa Leaders Summit

August 7, 2014

DALLAS, TX -- As part of the Investing In Our Future at the U.S. – Africa Leaders Summit hosted by First Lady Mrs. Michelle Obama and former First Lady Mrs. Laura Bush, Cryopen, Inc. participated in a Summit Marketplace on August 6, and presented the CryoPen® Cryosurgical System for Cervical Cancer Treatment to U.S. and African First Ladies and Summit guests. CryoPen, Inc. was part of a select group of companies and organizations chosen to participate in the Marketplace whose work is supporting women and girls in Africa.

read more

Spring Conference on Correctional Health Care

April 20-23, 2013

DENVER, CO -- Cryopen will be set up in booth #508 at the Spring Conference on Correctional Health Care in Denver, CO on April 20-23, 2013. Come and learn about CryoPen's innovative GYN attachment for the treatment of genital warts, CIN 1, CIN 2, and skin lesions WITHOUT Liquid Nitrogen or Nitrous Oxide.

read more

Medical Device Maker CryoPen, Inc. Selected to Present at WBT Innovative Marketplace in San Diego

October 2012

SAN DIEGO--(BUSINESS WIRE)--CryoPen, Inc., developer and maker of the CryoPen® Cryosurgical System, announced today it has been selected to be a presenter at the tenth annual WBT Innovation Marketplace presented by Northrup Grumman taking place October 24 – 26, 2012 at the San Diego Convention Center.

read more

CryoPen, Inc. Featured In Startech Foundation Annual Report

September 2012

In the past, an effective cryosurgical tool that was simple and safe to use without cryogenic gases or liquids did not exist or was not accessible to all physicians. Because of their focus on research, development,and production, CryoPen has created a revolutionary cryosurgical system that is easy to use, accessible to more physicians, and gives accurate, consistent results not dependent on technical issues such as gas pressures, volumes or other difficult to control variables.

read more

CryoPen Unveils Revolutionary New Cervical Cancer Treatment

GY2 Cryosurgical System Delivers Fast, Effective Treatment

August 15, 2012

Corpus Christi, Texas--(BUSINESS WIRE)--CryoPen, Inc., today announced that its new GY2 Cryosurgical System has been cleared by the Food and Drug Administration for use in gynecology. This new treatment will help medical professionals provide cervical cryosurgery without the traditional use of dangerous cryogenic gasses or liquids.

read more

Texas Emerging Technology Fund Awards CryoPen, Inc. $2,000,000

August 2008

Corpus Christi, Texas - CryoPen Inc. has been awarded a $2,000,000 technology development grant by the State of Texas Emerging Technology Fund (TETF) for the development and commercialization of the CryoPen Cryosurgical System®.

read more